Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4592 Target Snapshot

Amine oxidase [copper-containing] 3 · SINGLE PROTEIN · Rattus norvegicus

191Compounds
20Assays
1Approved Drugs
191.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O08590. Use UniProt O08590 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O08590 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Amine oxidase [copper-containing] 3 as ChEMBL target CHEMBL4592, mapped to UniProt O08590. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Amine oxidase [copper-containing] 3
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4592
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O08590
Amine oxidase [copper-containing] 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Amine oxidase [copper-containing] 3 is the right protein anchor across sources, using UniProt O08590 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAmine oxidase [copper-containing] 3
UniProt AccessionO08590
Component TypeProtein
Sequence Length763 aa

Amine oxidase [copper-containing] 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Amine oxidase [copper-containing] 3, mapped to UniProt O08590. Sequence length is 763 aa.

Mapped IDO08590
Review nameAmine oxidase [copper-containing] 3
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC50180.0
KI11.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL6003467 9.4 IC50 0.4 Preclinical
CHEMBL5892320 9.28 IC50 0.53 Preclinical
CHEMBL5741090 9.22 IC50 0.6 Preclinical
CHEMBL5852067 9.15 IC50 0.7 Preclinical
CHEMBL5896098 9.15 IC50 0.7 Preclinical
CHEMBL5801555 9.1 IC50 0.8 Preclinical
CHEMBL5973658 9.1 IC50 0.8 Preclinical
CHEMBL5816555 9.09 IC50 0.81 Preclinical
CHEMBL5901572 9.05 IC50 0.9 Preclinical
CHEMBL5937390 9.05 IC50 0.9 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
4
5.5
7
6.0
7
6.5
12
7.0
19
7.5
35
8.0
42
8.5
17
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

20
Total Assays
155
Tested Compounds
2
Assay Types
Binding — 19 assays, 155 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 8 8 6.2
cell-based format 5 34 6.5
assay format 4 109 8.4
cell-free format 1 3 5.5
tissue-based format 1 1 5.2
ADME — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 8.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine